You just read:

Tolerx Presents Preclinical Data on Novel Anti-GITR Cancer Immunotherapeutic Demonstrating Enhanced Anti-Tumor Responses

News provided by

Tolerx, Inc.

Apr 05, 2011, 09:00 ET